Immunopotentiation of tumor-bearing and toxohormone treated mice by human ceruloplasmin
Itoh, O.; Torikai, T.; Satoh, M.; Okumura, O.; Osawa, T.
Gan 72(5): 673-678
1981
ISSN/ISBN: 0016-450X PMID: 6976910 Document Number: 172372
Human ceruloplasmin was shown to have a restorative effect on the decrease of delayed hypersensitivity in sarcoma-180-bearing mice and of helper T-cell activity in cell-free. Ehrlich cancerous ascitic fluid-treated mice. Furthermore, it was also shown that ceruloplasmin augments the in vivo generation of alloreactive cytotoxic cell which consist of cytotoxic T-lymphocytes, cytotoxic macrophages and K cells.
Document emailed within 1 workday
Related Documents
Aicher, K.P.; Dupon, J.W.; White, D.L.; Aukerman, S.L.; Moseley, M.E.; Juster, R.; Rosenau, W.; Winkelhake, J.L.; Brasch, R.C. 1990: Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha Cancer Research 50(22): 7376-7381Itoh, O.; Torikai, T.; Satoh, M.; Okumura, O.; Osawa, T. 1981: Antitumor and toxohormone-neutralizing activities of human ceruloplasmin Gan 72(3): 370-376
Futami, H.; Jansen, R.; MacPhee, M.J.; Keller, J.; McCormick, K.; Longo, D.L.; Oppenheim, J.J.; Ruscetti, F.W.; Wiltrout, R.H. 1990: Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy Journal of Immunology 145(12): 4121-4130
Kien, C.L.; Holcenberg, J.S. 1981: Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase Cancer Research 41(6): 2051-2055
Tanaka, K.; Koga, Y.; Taniguchi, K.; Nomoto, K. 1987: T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state Cancer Research 47(8): 2136-2141
Giraldi, T.; Sava, G.; Perissin, L.; Zorzet, S. 1984: Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis carcinoma treated with proteinase inhibitors Anticancer Research 4(4-5): 221-224
Shi, X.B. 1990: Biodistribution and radioimmunoimaging of monoclonal antibody to human lung adenocarcinoma in tumor-bearing nude mice Zhonghua Zhong Liu Za Zhi 12(3): 179-182
Fisher, B.; Saffer, E.A. 1978: Tumor cells cytotoxicity by granulocytes from peripheral blood of tumor-bearing mice Journal of the National Cancer Institute 60(3): 687-691
Lu, L.; Xiao, M.; Wu, B.; Wang, W.X.; Yan, W.R.; Broxmeyer, H.E.; Shen, R.N. 1993: In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice International Journal of Hematology 58(3): 139-152
Iunker, V.M.; Arkhipov, S.A.; Gruntenko, E.V. 1984: Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system Biulleten' Eksperimental'noi Biologii i Meditsiny 98(11): 598-600
Zardi, L.; Cecconi, C.; Barbieri, O.; Carnemolla, B.; Picca, M.; Santi, L. 1979: Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells Cancer Research 39(9): 3774-3779
Tamura, K.; Ishida, N. 1984: Induction of tumor necrosis factor (TNF) in tumor-bearing mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1369-1378
Fine, D.L.; Arthur, L.O.; Gardner, M.B. 1978: Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice Journal of the National Cancer Institute 61(2): 485-491
Shi, L.; Chen, J.; Zhong, Q.; Geng, P.; He, J. 2014: Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice Zhonghua Zhong Liu Za Zhi 36(3): 177-182
Jin, A.; Qi, Y.; Mori, E.; Guo, M.; Takasaki, S.; Mori, T. 2004: Therapeutic effects of novel anti-tumor reagent, apoptosis inducing nucleosides from CD57+HLA-DRbright natural suppressor cell line on human gastric carcinoma-bearing SCID mice International Journal of Oncology 24(6): 1523-1528
Tzai, T.S.; Shiau, A.L.; Liu, L.L.; Wu, C.L. 2000: Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class i and Fas expressions Anticancer Research 20(3a): 1557-1562
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Zou, J.P.; Shimizu, J.; Ikegame, K.; Yamamoto, N.; Ono, S.; Fujiwara, H.; Hamaoka, T. 1992: Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity Journal of Immunology 148(2): 648-655
Fukatsu, H.; Yamada, H.; Nonomura, H.; Miyagawa, Y.; Hatano, Y.; Waki, M.; Hiraiwa, S.; Muramatsu, T.; Yamada, Y.; Nishikawa, E. 1987: Study on heterotransplantation of human malignant urogenital tumors in nude mice: establishment of the tumor line in nude mice from human primary ureteral tumor and its characteristics Hinyokika Kiyo. Acta Urologica Japonica 33(12): 1943-1950
Kamo, I.; Ishida, N. 1971: Immune response in tumor-bearing mice Gan 62(6): 453-458